All data is delayed
See More

DA wants Aspen anti-competitive actions probed

Apr 20 2017 18:58

The SA has asked the Competition Commission and the Medicines Control Council to investigate claims of anti-competitive behaviour by pharmaceutical firm Aspen.


Aspen shares drop over report of secret plan to destroy cancer drugs

Apr 18 2017 08:42

Aspen has responded to UK reports, which claim that it secretly planned to destroy cancer medicines as a threat to force countries in Europe to allow price hikes.


Novartis likely bribed 'thousands' in Greece - minister

Apr 07 2017 16:51

Swiss pharmaceutical giant Novartis likely bribed "thousands" of doctors and civil servants to promote its products, says Greece's justice minister.


EU approves Syngenta-ChemChina mega-deal

Apr 10 2017 17:59

EU antitrust authorities have cleared state-owned ChemChina's $43bn takeover of Swiss seeds giant Syngenta, the biggest ever overseas acquisition by a Chinese firm.


Adcock Ingram to acquire Virtual logistics

Apr 03 2017 11:20

Adcock Ingram has announced its acquisition of distribution company Virtual Logistics, in a move to expand its national footprint.


Ascendis CEO reveals health firm's cocktail for success

Mar 08 2017 20:03

Ascendis Health wants to make its business a proper empire and follows a different approach to SA, Africa and Europe in order to reach this goal, says the CEO.


Ascendis posts profit amid R1bn acquisition spree

Mar 08 2017 09:01

High growth health and care firm Ascendis Health has posted a 34% increase in half-year profit as it announced three acquisitions this month that will cost about R1bn.


Ascendis concludes 100% acquisition of Cipla

Mar 08 2017 18:59

Ascendis has announced the successful completion of the 100% acquisition of Cipla Agrimed SA and Cipla Vet SA.


Cipla to divest 100% stake in two companies

Mar 05 2017 15:00

Global pharmaceutical company Cipla announced on Sunday that it has agreed to divest its 100% stake in Cipla Agrimed SA and Cipla Vet SA to Ascendis Health.


Aspen signs off on GSK drug transaction

Mar 01 2017 16:33

Aspen Pharmacare says it has signed off on an agreement with GlaxoSmithKline to acquire a portfolio of anaesthetics.



Discovery still optimistic about UK business - CEO

Feb 23 2017 18:26

Discovery’s CEO Adrian Gore speaks to Fin24 about the company's interim results, as well as perspectives on global business opportunities.

We're talking about...


So, the worst has finally happened. S&P and Fitch officially downgraded SA to junk status following the ill-timed Cabinet reshuffle.

Money Clinic

Money Clinic
Do you have a question about your finances? We'll get an expert opinion.
Click here...

Voting Booth

Do you have a budget set aside for Easter holiday spending?

Previous results · Suggest a vote